Aptar Q2 sales up 16% to $811M, adj EPS $0.91 (+7%), core sales +10%; Q3 guidance $0.90-$0.98

APTARGROUP, INC.

2021-Q2 EPS reported $2.05 revenue$1,587,786,000

Reported sales $811M (+16% YoY); core sales +10% aided by double-digit growth in Beauty+Home and Food+Beverage.
Reported EPS $0.81 (+29%); adj EPS $0.91 (+7% neutralizing currency); net income $55M (+32%).
Pharma core sales +2% as destocking of allergic rhinitis/cough-cold inventory continues; elastomer demand strong.
Free cash flow H1 $39M (down 63%) due to higher capex and working capital; cash from ops $176M (-23%).
Q3 adj EPS guidance $0.90-$0.98; expects gradual improvement through H2 with acceleration toward year-end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.